Eaze, a San Francisco, CA-based on-demand medical marijuana technology company, completed a $13m Series B financing.
The round was led by Fresh VC with participation from DCM Ventures, Tusk Ventures, Winklevoss Capital, Rose Capital and others.
The company, which has raised more than $25m in total funding, intends to use the capital to accelerate product innovation, grow its team, and expand its technology to additional markets.
Launched in 2014 by Keith McCarty, CEO, Eaze provides a medical marijuana technology platform for patients to safely and discreetly order and receive deliveries from Proposition 215 compliant dispensaries from any connected device and premier dispensaries to automate delivery logistics, real-time inventory, and business intelligence insights.
Since launching in July 2014, the technology has powered on-demand dispensary deliveries to hundreds of thousands of medical marijuana patients in nearly 100 California cities.
FinSMEs
24/10/2016